• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Cervarix / Men more accepting of HPV vaccine when considering cancer reduction

Men more accepting of HPV vaccine when considering cancer reduction

January 11, 2011 By Jonathan Leave a Comment

VIHV Vaccine Injury Help Center

by RachelB.
Law Offices of Sadaka Associates on January 11, 2011

For several years, the cervical cancer vaccine Gardasil, and its European cousin Cervarix has been on the market with mixed reviews, to say the least.   Just as Indian health officials announced the cessation of trials surrounding the drug in their country due to the deaths of six young girls, other health care representatives are looking for ways to promote its use.  Gardasil, which is manufactured by Merck laboratories has been linked to a variety of autoimmune dysfunctions including Guillain Barre Syndrome, Lou Gehrig’s Disease, hair loss, coma, seizures and even death.  Some claim that government vaccination monitoring systems and the manufacturer are working over time to cover up complications, all while media hype plays up the benefits of a potentially deadly drug.

Over the course of the last several months, sales of Gardasil have been less than impressive. From $401 million in sales in 2008 to about half–just $286 million in 2009.  Research also shows that in combination with sagging sales, many young girls (only about 27%) are actually completing the three shot series that is required.  Specific reasons for cessation of the vaccination series are not being reported but extreme side effects in conjunction with better public knowledge regarding the risks are thought to be contributing.  In an attempt to sway the downward spiral, Merck has begun to market the drug for new uses–including reducing HPV and anal cancer risks in men and boys, and increasing its age use for women as old as 45.  An attempt to broaden the market is an attempt to broaden sales.

One common driving force for those who have had the HPV vaccine was an attempt to prevent cancer.  A recent study conducted at the University of North Carolina confirms that the fear of cancer itself is enough to encourage many, without knowing much else.  A group of 600 men ages 18-59 were asked if they would take a vaccine if it prevented genital warts, 42% said yes.  When reworded and ask if they would take a vaccine that prevented genital warts and cancer, 60% of those asked responded positively.

The study, which was published in the August 2010 issue of Cancer, Epidemiology, Biomarkers and Prevention and its author hopes the results will open a door of communication between health care providers and patients and focus on the cancer-preventing benefits of the vaccine.

Which, if you have read this blog for any length of time, will bring to remembrance the fact that true cancer prevention with this drug are questionable to say the least, as researchers and respected medical experts begin to voice concerns and speak out against the vaccine–supporting STD prevention, more responsible sexual practices and regular screenings and testing as an equally effective method of HPV control.

More…



Related

Filed Under: Cervarix, Gardasil / Silgard, STD's, Vaccine Marketing Tagged With: Anal Cancer, cervarix, Cervical Cancer HPV, Gardasil/Silgard, HPV, HPV VACCINES, pharmaceuticals, Sane Vax, STD's, Vaccine Adverse Reactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Gardasil in Italy: My daughter’s two year battle with new medical conditions

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

HPV Vaccine Side Effects Exposed

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in